MapLight Therapeutics, Inc. — Form D

MapLight Therapeutics, Inc. of REDWOOD CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-03-08. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (17)

NameRoleLocation
Jim A LillieExecutive OfficerMoffett Field, CA
Kristopher A HansonExecutive OfficerRedwood City, CA
Timothy A GarnettDirectorRedwood City, CA
George A PavlovDirectorRedwood City, CA
Peter A BisgaardDirectorRedwood City, CA
Erin A FoffExecutive OfficerRedwood City, CA
Anatol A KreitzerExecutive OfficerRedwood City, CA
Jim A TrenkleDirectorRedwood City, CA
James A LillieExecutive OfficerRedwood City, CA
Maria A WalkerDirectorRedwood City, CA
Christopher A KroegerDirectorRedwood City, CA
Christopher A KroegerExecutive OfficerRedwood City, CA
Jonathan A GillisExecutive OfficerRedwood City, CA
Vishwas A SetiaExecutive OfficerRedwood City, CA
Nanna A LuneborgDirectorRedwood City, CA
Robert A MalenkaDirectorRedwood City, CA
Charmaine A LykinsExecutive OfficerRedwood City, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2025-07-28D$372.4M$188.2M
2023-11-03D/A$225.0M$105.0M
2023-07-19D$175.0M$50.0M
2022-11-10D$12.0M$12.0M
2021-03-10D$60.0M$30.0M
2019-09-04D$16.0M$16.0M
2019-03-22D/A$5.0M$5.0M

More